Publications by authors named "David Mery"

Claim this Profile
E
Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans.
David E Mery, Guido Tricot, Samer Al Hadidi, Yihao Zhan, Cody Ashby

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.
Fumou Sun, Yan Cheng, Catherine Ma, Hongwei Xu, Clyde Bailey, David Mery

Cancer Biomark· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma.
Li Qin, Luz Yurany Moreno Rueda, Upasana Ray, Iqbal Mahmud, Lin Tan, David E Mery

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets.
Luz Yurany Moreno Rueda, Hua Wang, Keiko Akagi, Minghao Dang, Amishi Vora, David E Mery

Cell Rep Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.
Yan Cheng, Fumou Sun, Daisy V Alapat, Visanu Wanchai, David Mery

Blood Cancer J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
Xuehan Mao, Wenqiang Yan, David Mery, Jiahui Liu, Huishou Fan

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.
Wancheng Guo, Christopher Strouse, David Mery, Eric R Siegel, Manit N Munshi

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
Wancheng Guo, Yihao Zhan, David Mery, Eric R Siegel, Fumou Sun

Blood Cancer J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
Fumou Sun, Yan Cheng, Jin-Ran Chen, Visanu Wanchai, David E Mery

J Clin Invest· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Fumou Sun, Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS.
Wancheng Guo, Anne Zhan, David E Mery, Manit N Munshi, Oussama Makhoul

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.
Yan Cheng, Fumou Sun, Daisy V Alapat, Visanu Wanchai, David Mery

Cell Rep Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gene signature can predict risk of MGUS progressing to multiple myeloma.
Fumou Sun, Yan Cheng, Jun Ying, David Mery, Samer Al Hadidi

J Hematol Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Plant-Plant Interactions Reveals the Presence of Potent Antileukemic Compounds.
David E Mery, Amanda J Compadre, Paola E Ordóñez, Edward J Selvik, Vladimir Morocho

Molecules· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, Crystallography, and Anti-Leukemic Activity of the Amino Adducts of Dehydroleucodine.
Paola E Ordóñez, David E Mery, Krishan K Sharma, Saumyadip Nemu, William F Reynolds

Molecules· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells.
Laura M Bystrom, Daniel P Bezerra, Hsiao-Ting Hsu, Hongliang Zong, Luis A Lara-Martínez

Blood Adv· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does data cleaning disproportionately affect autistics?
David Panda Mery

Autism· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sister Earth, Our Common Home: Toward a Sustainable, Planet Friendly Approach to Dialysis, a Paradigm of High Technology Medicine.
Giorgina Barbara Piccoli, David Mery

J Ren Nutr· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis